Yayin da hukumomin lafiya na duniya ke fafutukar gano cutar kanjamau da wuri, masana'antun gano cutar suna hanzarta haɓaka dandamalin gwaji bisa ga antigen na p24, tare da gwaje-gwajen ƙarni na huɗu yanzu sun kai ga balaga ta kasuwanci a kasuwanni da yawa.

Antigen na p24, wani furotin mai ƙwayoyin cuta mai suna capsid, yawanci yana bayyana kwanaki 10 zuwa 14 bayan kamuwa da cutar HIV - kwanaki kafin a fara samun ƙwayoyin cuta. Wannan fa'idar halitta ta sanya p24 ya zama ginshiƙi na dabarun gwajin HIV na ƙarni na huɗu, waɗanda a lokaci guda ke gano antigen na p24 da ƙwayoyin cuta na HIV don rage lokacin ganewar asali.

Motsin Kasuwanci

A WHX Labs Bangkok 2026, kamfanin kera na'urorin bincike na kasar Sin Wondfo ya gabatar da gwajin gaggawa na HIV na ƙarni na huɗu ga Firayim Ministan Thailand Anutin Charnvirakul, inda ya nuna ikon gwajin na gano kamuwa da cuta kimanin mako guda kafin gwajin antibody kawai. Kamfanin ya bayar da rahoton cewa kashi 100% na masu kamuwa da cutar da kuma kashi 99.71% na takamaiman gwajin antibody na HIV-1/2 da kuma antigen na p24.

A Amurka, amincewar da aka samu daga hukumomi ta ci gaba da tafiya. Hukumar FDA ta share dandamali da dama na gano cutar p24 a shekarar 2026, ciki har da DiaSorin's LIAISON MUREX HIV Ab/Ag HT da kuma gwajin Abbott's HIV Combo Next na dandalin Alinity i. Dukansu suna wakiltar gwaje-gwajen rigakafi na chemiluminescent waɗanda ke iya gano cutar HIV p24 a lokaci guda tare da ƙwayoyin rigakafi ga HIV-1 da HIV-2.

Wani muhimmin ci gaba a fannin lafiyar jama'a ya zo ne a watan Yunin 2026, lokacin da Seychelles da Eritrea suka amince da Kwamitin Kula da Marayun da Abbott ya kafa - gwajin gaggawa na farko da WHO ta amince da shi wanda ya haɗa da gwajin cutar HIV na ƙarni na huɗu tare da syphilis da hepatitis B daga samfurin allurar yatsa guda ɗaya.

Yankunan Bincike

Bayan binciken kasuwanci, masu binciken ilimi suna bin diddigin gano p24 mai saurin kamuwa da cuta ta hanyar amfani da dandamalin microfluidic da nanomaterial. Wata ƙungiya daga Jami'ar Tsinghua kwanan nan ta ba da rahoton wani na'urar hangen nesa ta microfluorescent biosensor wanda ya cimma iyakar gano pg/mL 18.48 ga p24, ta amfani da dabarun ƙara siginar da ba ta da enzyme. A gefe guda kuma, masu binciken sun nuna tsarin microfluidic chemiluminescence tare da tsarin antibody da haɓaka siginar zinare ta nanoparticle, wanda ke mai da hankali kan aikace-aikacen kulawa a cikin saitunan da ba su da iyaka ga albarkatu.

Sharuɗɗan Asibiti

Duk da ci gaba, ƙalubale sun ci gaba. Wani bincike da aka gudanar a shekarar 2026 wanda ya kimanta gwajin VIDAS DUO AG/AB na bioMérieux akan wanda ya gabace shi ya gano yawan siginar antigen p24 marasa tabbas a lokacin rarrabuwar kamuwa da cuta mai tsanani, wanda ya nuna sarkakiyar ganewar asali a matakin farko. Bugu da ƙari, binciken da aka yi kwanan nan ya nuna cewa ana iya gano antigen p24 ne kawai bayan raba hadaddun garkuwar jiki a cikin samfuran da ke ɗauke da ƙwayoyin cuta fiye da kwafi 10⁴/mL, yana nuna cewa hadaddun garkuwar jiki da ke yawo na iya ɓoye gano antigen a wasu lokuta.

WHO tana da ƙa'idojin aiki don gano cutar HIV, tana buƙatar 100% na amsawa ga enzyme immunoasys waɗanda ke gano antigen na HIV-1/2 da HIV-1 p24, tare da takamaiman bayanai a ko sama da 98%.

Yayin da masana'antun ke inganta dandamali na ƙarni na huɗu da masu bincike ke ƙara ƙayyadadden iyakokin ganowa, binciken da aka yi bisa ga antigen na p24 yana shirye ya kasance babban abin da zai sa a ci gaba da amfani da dabarun duniya don gano kamuwa da cutar HIV mai tsanani da kuma katse hanyoyin yaɗa cutar.

Mu Baysen Medical za mu iya bayarwaKayan gwajin gaggawa na HIV/P24tare da gwajin inganci da adadi. Barka da zuwa tuntuɓar mu idan kuna da buƙata.